NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Cross Above 50 Day Moving Average – Should You Sell?

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) shares passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.00 and traded as high as $0.57. NovaBay Pharmaceuticals shares last traded at $0.57, with a volume of 1,162,340 shares changing hands.

NovaBay Pharmaceuticals Stock Up 5.6 %

The firm has a market capitalization of $2.40 million, a PE ratio of -0.06 and a beta of 2.82.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.